Causes and Characteristics of Diabetic Cardiomyopathy
Authors:
- 1 January 2006
- journal article
- Published by Raiya Academic International LLC in The Review of Diabetic Studies
- Vol. 3 (3) , 108
Abstract
Type 1 and type 2 diabetic patients are at increased risk of cardiomyopathy and heart failure is a major cause of death for these patients. Cardiomyopathy in diabetes is associated with a cluster of features including decreased diastolic compliance, interstitial fibrosis and myocyte hypertrophy. The mechanisms leading to diabetic cardiomyopathy remain uncertain. Diabetes is associated with most known risk factors for cardiac failure seen in the overall population, including obesity, dyslipidemia, thrombosis, infarction, hypertension, activation of multiple hormone and cytokine systems, autonomic neuropathy, endothelial dysfunction and coronary artery disease. In light of these common contributing pathologies it remains uncertain whether diabetic cardiomyopathy is a distinct disease. It is also uncertain which factors are most important to the overall incidence of heart failure in diabetic patients. This review focuses on factors that can have direct effects on diabetic cardiomyocytes: hyperglycemia, altered fuel use, and changes in the activity of insulin and angiotensin. Particular attention is given to the changes these factors can have on cardiac mitochondria and the role of reactive oxygen species in mediating injury to cardiomyocytes.Keywords
This publication has 80 references indexed in Scilit:
- Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetesAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Cardiac Expression of Kinase-deficient 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Inhibits Glycolysis, Promotes Hypertrophy, Impairs Myocyte Function, and Reduces Insulin SensitivityJournal of Biological Chemistry, 2004
- Attenuation of fatty acid-induced apoptosis by low-dose alcohol in neonatal rat cardiomyocytesAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Lipotoxic DiseasesAnnual Review of Medicine, 2002
- Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventionsCardiovascular Research, 1997
- Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (The Framingham Heart Study)The American Journal of Cardiology, 1991
- Specific heart muscle disease in diabetes mellitus — a functional structural correlationInternational Journal of Cardiology, 1987
- Quantitative approach to the histopathology of the biopsied right ventricular myocardium in patients with diabetes mellitusHeart and Vessels, 1985
- Role of diabetes in congestive heart failure: The Framingham studyThe American Journal of Cardiology, 1974
- New type of cardiomyopathy associated with diabetic glomerulosclerosisThe American Journal of Cardiology, 1972